Download PDF
Zentralbl Chir 2003; 128(10): 796-803
DOI: 10.1055/s-2003-44334
Originalarbeiten und Übersichten

© Georg Thieme Verlag Stuttgart · New York

Mechanische Kreislaufunterstützung bei akuter und chronischer Herzinsuffizienz - eine Standortbestimmung unter besonderer Berücksichtigung der Entwicklung in Deutschland

Mechanical Circulatory Assist Devices in Acute and Chronic Heart FailureJ. Martin1 , M. P. Siegenthaler1 , M. Krause1 , O. Friesewinkel1 , F. Beyersdorf1
  • 1Abteilung für Herz- und Gefäßchirurgie der Albert-Ludwigs-Universität, Freiburg im Breisgau
Further Information

Publication History

Publication Date:
20 November 2003 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Der Einsatz mechanischer Kreislaufunterstützungssysteme, die vor allem zur Überbrückung der Wartezeit bis zur Herztransplantation Verwendung finden, hat sich bei vielen Patienten als lebensrettende Maßnahme erwiesen. In den letzten Jahren konnten die Kreislaufpumpen unter Berücksichtigung der klinischen Erfahrungen technisch erheblich weiterentwickelt werden. Die immer besseren Ergebnisse haben auch zu einer großzügigeren Indikationsstellung und breiteren Anwendung der sog. „Assist Devices ” geführt. Mit den Axialpumpen stehen heute Systeme zur Verfügung, die für einen langfristigen Einsatz konzipiert sind. Sollte es gelingen, die derzeitigen Probleme dieser Systeme (vor allem thromboembolische Komplikationen) deutlich zu reduzieren, könnten sie zukünftig eine Alternative zur Herztransplantation darstellen.

Abstract

The clinical use of mechanical circulatory assist devices as bridge to transplantation has been proved as life-saving therapy in a large population of patients. Learning from the clinical experience the construction of the blood pumps has been markedly improved over the last years. The better outcome of the patients has enabled a broader use of ventricular assist devices. The novel axial pumps are designed for long-term circulatory support. After further reduction of device related complications (first of all thromboembolic events) these systems may provide a future alternative to heart transplantation.

Schlüsselwörter

Assist Devices - mechanische Kreislaufunterstützung - Kunstherz - Blutpumpen - Herzinsuffizienz

Key words

Assist devices - mechanical circulatory support - artificial heart - blood pumps - heart failure

Literatur

  • 1 Arrow International Inc. LionHeart left ventricular assist system. Arrow International Inc., Reading, PA. www.arrowlionheart.com
    Google Scholar
  • 2 Beyersdorf F. Economics of ventricular assist devices: European view.  Ann Thorac Surg. 2001;  71 192-194
    CrossrefPubMedGoogle Scholar
  • 3 Copeland J G, Pavie A, Duveau D, Keon W J, Masters R, Pifarre R, Smith R G, Arabia F A. Bridge to transplantation with the CardioWest total artificial heart: the international experience 1993-1995.  J Heart Lung Transplant. 1996;  15 94-99
    PubMedGoogle Scholar
  • 4 Copeland J G, Smith R G, Arabia F A, Nolan P E, Mehta V K, McCarthy M S, Chisholm K A. Comparison of the CardioWest total artificial heart, the Novacor left ventricular assist system and the thoratec ventricular assist system in bridge to transplantation.  Ann Thorac Surg. 2001;  71 92-97
    CrossrefPubMedGoogle Scholar
  • 5 Cooley D A. Staged cardiac transplantation: a report of three cases.  J Heart Transplant. 1982;  1 145-153
    PubMedGoogle Scholar
  • 6 DeRose J J, Umana J P, Argenziano M, Catanese K A, Levin H R, Sun B C, Rose E A, Oz M C. Improved results for postcardiotomy cardiogenic shock with the use of implantable left ventricular assist devices.  Ann Thorac Surg. 1997;  64 1757-1762
    CrossrefPubMedGoogle Scholar
  • 7 DeBakey M E. A miniature implantable axial flow ventricular assist device.  Ann Thorac Surg. 1999;  68 637-640
    CrossrefPubMedGoogle Scholar
  • 8 Deng M C, Loebe M, El-Banayosy A, Gronda E, Jansen P GM, Vigano M, Wieselthaler G M, Reichart B, Vitali E, Pavie A, Mesana T, Loisance D Y, Wheeldon D R, Portner P M. Mechanical circulatory support for advanced heart failure. Effect of patient selection on outcome.  Circulation. 2001;  103 231-237
    PubMedGoogle Scholar
  • 9 DeVries W C, Anderson J L, Joyce L D, Anderson F C, Hammond E H, Jarvik R, Kolf W J. Clinical use of the total artificial heart.  NEJM. 1984;  310 273-278
    PubMedGoogle Scholar
  • 10 Dowling R K, Etoch S W, Stevens K A, Johnson A C, Gray L A. Current status of the AbioCor implantable replacement heart.  Ann Thorac Surg. 2001;  71 147-149
    CrossrefPubMedGoogle Scholar
  • 11 Drews T, Loebe M, Hennig E, Kaufmann F, Muller J, Hetzer R. The ‘Berlin Heart’ assist device.  Perfusion. 2000;  15 387-396
    PubMedGoogle Scholar
  • 12 El-Banayosy A, Deng M, Loisance D Y, Vetter H, Granda E, Loebe M, Vigano M. The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study.  Eur J Cardiothorac Surg. 1999;  15 835-841
    CrossrefPubMedGoogle Scholar
  • 13 El-Banayosi A, Arusoglu L, Kizner L, Tenderich G, Boethig D, Minami K, Körfer R. Predictors of survival in patients bridged to transplantation with the thoratec VAD device: a single-center retrospective study on more than 100 patients.  J Heart Lung Transplant. 2000;  19 964-968
    PubMedGoogle Scholar
  • 14 El-Banayosy A, Fey O, Sarnowski P, Arusoglu L, Boethig D, Milting K, Morshuis M, Körfer R. Midterm follow-up of patients discharged from hospital under left ventricular assistance.  J Heart Lung Transplant. 2001;  20 53-58
    CrossrefPubMedGoogle Scholar
  • 15 Frazier O H, Rose E A, Oz M C, Dembitsky W, McCarthy P, Radovancevic B. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation.  J Thorac Cardiovasc Surg. 2001;  122 1186-1195
    CrossrefPubMedGoogle Scholar
  • 16 Goldstein D J. Thermo cardiosystems ventricular assist devices. In: Goldstein DJ, Oz MC (eds). Cardiac assist devices. Futura Publishing Co, Inc, Armonk, NY 2000; 307 -321
    Google Scholar
  • 17 Holman W L, Skinner J L, Waites K B, Benza R L, McGiffin M D, Kirklin J K. Infection during circulatory support with ventricular assist devices.  Ann Thorac Surg. 1999;  68 711-716
    CrossrefPubMedGoogle Scholar
  • 18 Holman W L, Davies J E, Rayburn B K, McGiffin D C, Foley B A, Benza R L, Bourge R C, Blood P, Kirklin J K. Treatment of end-stage heart disease with outpatient ventricular assist devices.  Ann Thorac Surg. 2002;  73 1489-1493
    CrossrefPubMedGoogle Scholar
  • 19 Itescu S, Ankersmit J H, Kocher A A, Schuster M D. Immunobiology of left ventricular assist devices.  Prog Cardiovasc Dis. 2000;  43 67-80
    PubMedGoogle Scholar
  • 20 John R, Lietz K, Burke E, Ankersmit J, Mancini D, Suciu-Foca N, Edwards N, Rose E, Oz M, Itescu S. Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients.  Circulation. 1999;  100 (Suppl 2) 229-235
    PubMedGoogle Scholar
  • 21 Koster A, Loebe M, Hansen R, Potapov E V, Noon G PO, Kuppe H, Hetzer R. Alterations in coagulation after implantation of a pulsatile Novacor LVAD and the axial flow MicroMed DeBakey LVAD.  Ann Thorac Surg. 2000;  70 533-537
    CrossrefPubMedGoogle Scholar
  • 22 Long J W. Advanced mechanical circulatory support with the Heart Mate left ventricular assist device in the year 2000.  Ann Thorac Surg. 2001;  71 176-182
    CrossrefPubMedGoogle Scholar
  • 23 Massad M G, Cook D J, Schmitt S K, Smedira N G, McCarthy J F, Vargo R L, McCarthy P M. Factors influencing HLA sensitation in implantable LVAD recipients.  Ann Thorac Surg. 1997;  64 1120-1125
    CrossrefPubMedGoogle Scholar
  • 24 Mehta S M, Pae W E, Rosenberg G, Snyder A J, Weiss W J, Lewis J P. et al . The LionHeart LVD-2000: a completely implanted left ventricular asasist device for chronic circulatory support.  Ann Thorac Surg. 2001;  71 156-161
    CrossrefPubMedGoogle Scholar
  • 25 Meyns B, Autschbach R, Boning A, Konertz W, Matschke K, Schondube F, Wiebe K, Fischer E. Coronary artery bypass grafting supported with intracardiac microaxial pumps versus normothermic cardiopulmonary bypass: a prospective randomized trial.  Eur J Cardiothorac Surg. 2002;  22 112-117
    CrossrefPubMedGoogle Scholar
  • 26 Ochiai Y, McCarthy P, Smedira N G, Banbury M K, Navia J L, Feng J, Hsu A P, Yeager M L. et al . Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients.  Circulation. 2002;  106 (Suppl 1) 198-202
    CrossrefPubMedGoogle Scholar
  • 27 Oz M C, Goldstein D J, Pepino P, Weinberg A D, Thompson S M, Catanese K, Vargo R L, McCarthy P M, Rose E A, Levin H R. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices.  Circulation. 1995;  92 169-173
    PubMedGoogle Scholar
  • 28 Oz M C, Argenziano M, Catanese K A, Gardocki M T, Goldstein D J, Ashtom R C, Gelijins A C, Rose E A, Levin H R. Bridge experience with long-term implantable left ventricular assist devices.  Circulation. 1997;  95 1844-1852
    PubMedGoogle Scholar
  • 29 Pasque M K, Rogers J G. Adverse events in the use of HeartMate vented electric and Novacor left ventricular assist devices: Comparing apples and oranges.  J Thorac Cardiovasc Surg. 2002;  124 1063-1067
    CrossrefPubMedGoogle Scholar
  • 30 Portner P M, Jansen P GM, Oyer P M, Wheeldon D R, Ramasamy N. Improved outcomes with an implantable left ventricular assist system: a multicenter study.  Ann Thorac Surg. 2001;  71 205-209
    CrossrefPubMedGoogle Scholar
  • 31 Reichenbach S H, Farrar D J, Hill J D. A versatile intracorporeal ventricular assist device based on the Thoratec VAD system.  Ann Thorac Surg. 2001;  71 171-175
    CrossrefPubMedGoogle Scholar
  • 32 Rose E A, Gelijns A C, Moskowitz A J, Heitjan D, Stevenson L W, Dembitsky W, Long J W, Ascheim D D. Long-term use of a left ventricular assist device for end-stage heart failure.  N Engl J Med. 2001;  345 1435-1443
    CrossrefPubMedGoogle Scholar
  • 33 Siegenthaler M P, Martin J, van de Loo A, Doenst T, Bothe W, Beyersdorf F. Implantation of the permanent Jarvik-2000 left ventricular assist device: a single-center experience.  J Am Coll Cardiol. 2002;  39 1764-1772
    CrossrefPubMedGoogle Scholar
  • 34 Thuaudet S. The Medos ventricular assist device system.  Perfusion. 2000;  15 337-343
    PubMedGoogle Scholar
  • 35 Westaby S, Banning A P, Jarvik R. et al . First permanent implant of the Jarvik 2000 Heart.  Lancet. 2000;  356 900-903
    CrossrefPubMedGoogle Scholar

PD Dr. J. Martin

Abteilung für Herz- und Gefäßchirurgie

Albert-Ludwigs-Universität Freiburg i. Br.

Hugstetter Str. 55

79106 Freiburg

Phone: 07 61/2 70 28 18

Fax: 07 61/2 70 25 50

Email: Martin@ch11.ukl.uni-freiburg.de